Brief: Zimmer Biomet Q3 Adjusted EPS USD 1.9 Vs. IBES Estimate USD 1.88
05/11/2025 11:30
Nov 05 (Reuters) - Zimmer Biomet Q3 net income USD 230.9 million. Q3 sales USD 2,001 million vs. IBES estimate USD 2,004 million Q3 EPS USD 1.16 outlook FY adjusted EPS USD 8.1-8.3
Recent news on Zimmer Biomet Holdings
See all newsMedical device makers slip in sympathy with J&J's MedTech miss
Brief: Zimmer Biomet And THINK Surgical Extend Exclusive Distribution Agreement
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Stryker taps insider Stiles to succeed industry veteran Lobo as CEO